JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Baseline Ga-68 PSMA PET-Derived Primary Tumor Parameters in Patients with Prostate Cancer and Their Association with Clinical Risk Stratification and Clinicopathologic Features

  • 0Department of Nuclear Medicine, University of Health Sciences, Başakşehir Cam and Sakura City Hospital, Istanbul, Türkiye.
World Journal of Nuclear Medicine +

|

December 16, 2024

|

December 16, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Gallium-68-labeled prostate-specific membrane antigen (68Ga-PSMA) PET/CT parameters can differentiate prostate cancer (PCa) risk groups. Total lesion PSMA (TL-PSMA) is the most effective parameter for distinguishing all risk categories.

Area Of Science

  • Nuclear Medicine
  • Oncology
  • Radiomics

Background

  • Prostate cancer (PCa) staging and risk stratification are crucial for treatment planning.
  • Gallium-68-labeled prostate-specific membrane antigen (68Ga-PSMA) PET/CT is increasingly used for PCa imaging.
  • The utility of quantitative parameters from 68Ga-PSMA PET/CT in predicting PCa characteristics requires further evaluation.

Purpose Of The Study

  • To assess the association between 68Ga-PSMA PET/CT parameters of primary PCa lesions and established prognostic factors.
  • To determine if imaging parameters correlate with Gleason score (GS), D'Amico risk class, Candiolo nomogram risk groups, and metastatic status.
  • To identify the most effective PSMA-derived parameter for risk stratification.

Main Methods

  • Retrospective analysis of 68Ga-PSMA PET/CT scans from newly diagnosed PCa patients before therapy.
  • Quantitative analysis of primary tumor parameters including SUVmax, SUVmean, PSMA-derived tumor volume (PSMA-TV), and total lesion PSMA (TL-PSMA).
  • Patients were categorized by GS (≤7 vs. ≥8), D'Amico risk class (intermediate vs. high), and Candiolo nomogram risk groups (low, intermediate, high).

Main Results

  • Significant differences in SUVmean, SUVmax, PSMA-TV, and TL-PSMA were observed across different GS, D'Amico, and Candiolo risk groups.
  • 44 (36.7%) patients had detectable PSMA-positive metastases.
  • TL-PSMA was the only parameter that demonstrated significant variation across all evaluated risk groups, including metastatic versus nonmetastatic status.

Conclusions

  • Primary tumor parameters derived from baseline 68Ga-PSMA PET/CT are valuable for distinguishing PCa patients based on GS, D'Amico risk, Candiolo nomogram, and metastatic status.
  • TL-PSMA emerges as the superior imaging biomarker, capable of differentiating all risk strata.
  • These findings support the integration of quantitative 68Ga-PSMA PET/CT metrics into routine PCa assessment for improved risk stratification.

Keywords: